Zynex has developed NexWave, a new product in its electrotherapy product line. The product is based on the company’s existing hardware platform and is expected to deliver transcutaneous electrical nerve stimulation, interferential current as well as neuromuscular electrical stimulation.
Zynex said that the NeuroMove is an electrotherapy device which is used for stroke and spinal cord injury (SCI) rehabilitation.
Thomas Sandgaard, CEO, said: “We expect that demand will be good for this new and versatile product. We introduced prototypes of the NexWave to our sales-force during our June National Sales Meeting at our new corporate headquarters and are hopeful our sales representatives will be able to begin introducing it to their physician and therapist customers in late 2010.”
Zynex is a medical device company that engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets: standard digital electrotherapy products for pain relief and pain management; and the NeuroMove for stroke and spinal cord injury (SCI) rehabilitation.